Glazer Capital’s Pardes Biosciences PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-265,631
Closed -$2.64M – 940
2021
Q3
$2.64M Sell
265,631
-193,622
-42% -$1.92M 0.05% 364
2021
Q2
$4.58M Sell
459,253
-433,744
-49% -$4.35M 0.07% 304
2021
Q1
$8.89M Buy
+892,997
New +$9.23M 0.13% 231

Other funds holding PRDS

Glazer Capital's PRDS Position: Q4 2021 in Review

Glazer Capital sold out of Pardes Biosciences (PRDS) in Q4 2021, closing a stake of 265,631 shares — an estimated $2.64M sold.

Glazer Capital first reported a position in PRDS in Q1 2021 and held it in 3 quarters. The position peaked at $8.89M in Q1 2021. 41 funds tracked by Wall St. Rank hold PRDS as of Q4 2021.

  • Glazer Capital reported no remaining Pardes Biosciences position as of Q4 2021 after selling out during the quarter.
  • Glazer Capital sold 265,631 Pardes Biosciences shares in Q4 2021, an estimated $2.64M.
  • Glazer Capital first reported a position in Pardes Biosciences in Q1 2021 and held it in 3 quarters.
  • Glazer Capital's Pardes Biosciences position peaked at $8.89M in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Pardes Biosciences as of Q4 2021.

Based on Glazer Capital's 13F filing for Q4 2021, filed 14 Feb 2022.